Stay informed with the latest litigation news. Explore now

IP Verse

Process For Preparation Of Apremilast - EP3341359B2

EP3341359

GLENMARK LIFE SCIENCES
Application Number
EP16838641A
Filing Date
Aug 22, 2016
Status
Patent Maintained As Amended
Dec 20, 2024
Grant Date
Jan 22, 2025
External Links
Slate, Register, Google Patents

Bibliography

The patent EP3341359B2 was granted to Glenmark Life Sciences on Jan 22, 2025 following the initial filing on Aug 22, 2016 under the application number EP16838641A . The current legal status of the patent is Patent Maintained As Amended.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

HAMM & WITTKOPPDec 22, 2022ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents